Growth and development in a heliox incubator environment: a long-term safety study

Clifford J Singhaus1, Levon H Utidjian, Robert E Akins

  • 1Nemours Research Lung Center, Alfred I. duPont Hospital for Children/Nemours Research Lung Center, Wilmington, DE 19803, USA.

Neonatology
|March 9, 2007
PubMed

Insights

Heliox gas is safe for neonates with bronchopulmonary dysplasia (BPD), showing no negative effects on growth or development. This finding supports further clinical trials for BPD treatment.

Area of Science:

  • Neonatal care
  • Respiratory medicine
  • Pediatric pulmonology

Background:

  • Mechanical ventilation can lead to bronchopulmonary dysplasia (BPD) in neonates.
  • BPD increases energy expenditure, potentially hindering growth and development.
  • Heliox therapy may improve pulmonary function and reduce energy demands.

Purpose of the Study:

  • To evaluate the safety of heliox exposure in a neonatal model.
  • To assess heliox's impact on growth, development, and physiological parameters.
  • To determine if heliox supports sustained growth in a BPD-relevant context.

Main Methods:

  • Neonatal rabbit pups were randomized into control or heliox groups.
  • Animals were raised for 14 days under controlled environmental conditions.
  • Developmental milestones, growth parameters, blood chemistry, and tissue/muscle analysis were conducted.

Main Results:

  • All pups in both groups thrived and met developmental milestones.
  • No significant differences were observed in weight, growth factors, or tissue/muscle characteristics.
  • Blood chemistry and muscle enzyme activity remained within normal physiological ranges.

Conclusions:

  • Long-term heliox exposure demonstrated safety in the studied rabbit model.
  • No adverse effects on growth or development were detected.
  • Heliox may offer a therapeutic window for pulmonary improvement in BPD neonates, justifying clinical trials.
Abstract